secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2022-05-10T23:59:59+00:00
Accession:  0001636422-22-000023
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q1 revenue $68.1M (+22% YoY), positive Adjusted EBITDA $671K
----------------------------------------------------------------------------

- Total revenue $68.1M, +22% YoY; technology revenue $42.2M (+25%), professional services $25.9M (+17%).
- Adjusted EBITDA turned positive to $0.7M from -$0.8M in Q1 2021; net loss narrowed 21% to $22.5M.
- Adjusted Technology Gross Margin improved to 70% (from 69%); Professional Services margin slipped to 29% (from 31%).
- CEO says Q1 exceeded midpoint of guidance for both revenue and Adjusted EBITDA; achieved Adjusted EBITDA breakeven milestone.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642222000023/0001636422-22-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642222000023/hcat-20220510.htm
  HTML page:      https://secwatch.observer/filing/0001636422-22-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer